New Progress in the Treatment of Alzheimer’s Disease

阿尔兹海默症是一种严重的神经退行性疾病,主要表现为认知功能障碍和记忆力衰退。近年来,随着对阿尔兹海默症病理机制的深入研究,治疗方法也在不断进步,阿尔兹海默症作为神经退行性疾病领域的研究焦点,其药物治疗及多靶点干预策略正经历从“症状缓解”到“病理干预”的革命性转变。本文将重点阐述阿尔兹海默症发病机制、药物治疗、非药物治疗及多靶点策略的研究进展,以期为阿尔兹海默症的治疗策略提供新的思路。Alzheimer’s disease is a grave neurodegenerative disorder, predominantly manifested by cognitive impairments and memory deterioration. In recent years, along with the profound exploration of the pathological mechanisms of Alzheimer’s disease, therapeutic approaches have been evolving steadily. As a central research focus within the realm of neurodegenerative diseases, the pharmaceutical treatment strategies for Alzheimer’s disease are experiencing a revolutionary shift from “symptom alleviation” to “pathological intervention”. This paper will comprehensively elaborate on the research advancements regarding the pathogenesis, pharmaceutical treatments, and strategies of Alzheimer’s disease, with the aim of offering novel perspectives for the treatment strategies of this condition.

Authors

Publication Details

Journal
Advances in Clinical Medicine
Published
2025-01-01
DOI
https://doi.org/10.12677/acm.2025.1561810
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Progress in the Treatment of Alzheimer’s Disease

玉婷 朱
Advances in Clinical Medicine
Alzheimer's disease research and treatments
article

New Progress in the Treatment of Alzheimer’s Disease

玉婷 朱
article en

Abstract

阿尔兹海默症是一种严重的神经退行性疾病,主要表现为认知功能障碍和记忆力衰退。近年来,随着对阿尔兹海默症病理机制的深入研究,治疗方法也在不断进步,阿尔兹海默症作为神经退行性疾病领域的研究焦点,其药物治疗及多靶点干预策略正经历从“症状缓解”到“病理干预”的革命性转变。本文将重点阐述阿尔兹海默症发病机制、药物治疗、非药物治疗及多靶点策略的研究进展,以期为阿尔兹海默症的治疗策略提供新的思路。Alzheimer’s disease is a grave neurodegenerative disorder, predominantly manifested by cognitive impairments and memory deterioration. In recent years, along with the profound exploration of the pathological mechanisms of Alzheimer’s disease, therapeutic approaches have been evolving steadily. As a central research focus within the realm of neurodegenerative diseases, the pharmaceutical treatment strategies for Alzheimer’s disease are experiencing a revolutionary shift from “symptom alleviation” to “pathological intervention”. This paper will comprehensively elaborate on the research advancements regarding the pathogenesis, pharmaceutical treatments, and strategies of Alzheimer’s disease, with the aim of offering novel perspectives for the treatment strategies of this condition.

Advances in Clinical MedicineVol. 15(06)
Openalex Percentile: Top 81%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.